Press Releases
Filter By Year
2023
-
February 22, 2023
Kite Completes Acquisition of Tmunity -
February 09, 2023
Kite’s Tecartus® CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia -
February 02, 2023
Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results
Filter By Year